Found: 4
Select item for more details and to access through your institution.
Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab‐induced bullous pemphigoid.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090353
- By:
- Publication type:
- Article
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 4, p. 619, doi. 10.1007/s00262-019-02308-w
- By:
- Publication type:
- Article
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.976837
- By:
- Publication type:
- Article